NEW YORK (dpa-AFX) – Another attempt at recovery is emerging on the US stock exchanges in the middle of the week. Three quarters of an hour before the start of trading, the broker IG valued the Dow Jones Industrial (Dow Jones 30 Industrial) just under one percent higher at 34 825 points and the NASDAQ 100 almost one and a half percent up at 16 374 points.
The day before, both indices had visibly suffered from ongoing fears about the new Coron variant Omikron and indications of an earlier than expected tightening of US monetary policy. But while the leading index ultimately recorded a minus of 3.7 percent for November, the technology-heavy selection index achieved a monthly plus of 1.8 percent. In the year to date, the Nasdaq 100 is clearly ahead.
The fact that an advisory committee to the US FDA recommended emergency approval for a corona drug from Merck & Co (Merck) gave the pharmaceutical company a pre-market price increase of around one percent. The recommendation is not binding on the FDA, but the authority usually follows the assessment of the consultant. Emergency approval from the FDA could now follow within a few days.
In contrast, a cautious outlook caused the shares of the software company Salesforce to fall by almost five percent. In contrast, business in the past quarter went better than expected. The share certificates from competitor Oracle were unimpressed by the market reaction to Salesforce: They were more expensive by over one percent.
The situation was similar to that of Salesforce at the information technology company Hewlett Packard Enterprise: Here, too, a disappointing outlook outweighed a good quarterly report, so that the papers lost around 1.7 percent before the market. / Gl / jha /
–
TRADE FOREIGN EXCHANGE WITH UP TO LEVER 30 NOW
Trade forex with high leverage and small spreads. With only € 100.00 you can benefit from the effect of € 3,000 in capital.
–
72% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford the high risk of losing your money.
–
– .
